Pfizer JKI 5 (Xeljanz 5 mg)
Generic Name: tofacitinib
Pill with imprint Pfizer JKI 5 is White, Round and has been identified as Xeljanz 5 mg. It is supplied by Pfizer, Inc..
Xeljanz is used in the treatment of rheumatoid arthritis; ulcerative colitis; psoriatic arthritis; juvenile idiopathic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer JKI 5
Xeljanz
- Generic Name
- tofacitinib
- Imprint
- Pfizer JKI 5
- Strength
- 5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer, Inc.
- National Drug Code (NDC)
- 00069-1001
More about Xeljanz (tofacitinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 116 Reviews
- Drug class: antirheumatics
- FDA Alerts (3)
- FDA Approval History
Consumer resources
- Other brands
- Xeljanz XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.